In vitro stimulation of bronchoalveolar lavage cells from patients with chronic
beryllium disease (CBD) induces the production of
TNF-alpha. We tested the hypothesis that
beryllium (Be)-stimulated
TNF-alpha might induce apoptosis in mouse and human macrophage cell lines. These cell lines were selected because they produce a range of Be-stimulated
TNF-alpha. The mouse macrophage cell line H36.12j produces high levels of Be-stimulated
TNF-alpha. The mouse macrophage cell line P388D.1 produces low, constitutive, levels of
TNF-alpha and does not up-regulate Be-stimulated
TNF-alpha production. The DEOHS-1 human CBD macrophage cell line does not produce constitutive or Be-stimulated
TNF-alpha. Apoptosis was determined by microscopic observation of
propidium iodide stained fragmented nuclei in unstimulated and BeSO(4)-stimulated macrophage cell lines. BeSO(4) induced apoptosis in all macrophage cell lines tested.
Beryllium-stimulated apoptosis was dose-responsive and maximal after 24 h of exposure to 100 microM BeSO(4). In contrast, unstimulated and Al(2)(SO(4))(3)-stimulated macrophage cell lines did not undergo apoptosis. The general
caspase inhibitor BD-fmk inhibited Be-stimulated macrophage cell line apoptosis at concentrations above 50 microM. Our data show that Be-stimulated macrophage cell line apoptosis was
caspase-dependent and not solely dependent on Be-stimulated
TNF-alpha levels. We speculate that the release of Be-
antigen from apoptotic macrophages may serve to re-introduce Be material back into the lung microenvironment, make it available for uptake by new macrophages, and thereby amplify Be-stimulated
cytokine production, promoting ongoing
inflammation and
granuloma maintenance in CBD.